A citation-based method for searching scientific literature

Boris P Kovatchev. Nat Rev Endocrinol 2017
Times Cited: 89



Thomas Danne, Revital Nimri, Tadej Battelino, Richard M Bergenstal, Kelly L Close, J Hans DeVries, Satish Garg, Lutz Heinemann, Irl Hirsch, Stephanie A Amiel, Roy Beck, Emanuele Bosi, Bruce Buckingham, Claudio Cobelli, Eyal Dassau, Francis J Doyle, Simon Heller, Roman Hovorka, Weiping Jia, Tim Jones, Olga Kordonouri, Boris Kovatchev, Aaron Kowalski, Lori Laffel, David Maahs, Helen R Murphy, Kirsten Nørgaard, Christopher G Parkin, Eric Renard, Banshi Saboo, Mauro Scharf, William V Tamborlane, Stuart A Weinzimer, Moshe Phillip. Diabetes Care 2017
Times Cited: 536




List of shared articles



Times cited

The Relationships Between Time in Range, Hyperglycemia Metrics, and HbA1c.
Roy W Beck, Richard M Bergenstal, Peiyao Cheng, Craig Kollman, Anders L Carlson, Mary L Johnson, David Rodbard. J Diabetes Sci Technol 2019
87

Spousal Influence on Diabetes Self-care: Moderating Effects of Distress and Relationship Quality on Glycemic Control.
Emily C Soriano, James M Lenhard, Jeffrey S Gonzalez, Howard Tennen, Sy-Miin Chow, Amy K Otto, Christine Perndorfer, Biing-Jiun Shen, Scott D Siegel, Jean-Philippe Laurenceau. Ann Behav Med 2021
0

Time in Range: How to Measure It, How to Report It, and Its Practical Application in Clinical Decision-Making.
Eugene E Wright, Kayla Morgan, Danny K Fu, Nick Wilkins, William J Guffey. Clin Diabetes 2020
0

Glycaemic variability in diabetes: clinical and therapeutic implications.
Antonio Ceriello, Louis Monnier, David Owens. Lancet Diabetes Endocrinol 2019
112



Hybrid Closed-Loop Control Is Safe and Effective for People with Type 1 Diabetes Who Are at Moderate to High Risk for Hypoglycemia.
Stacey M Anderson, Bruce A Buckingham, Marc D Breton, Jessica L Robic, Charlotte L Barnett, Christian A Wakeman, Mary C Oliveri, Sue A Brown, Trang T Ly, Paula K Clinton,[...]. Diabetes Technol Ther 2019
15

Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment.
Aika Miya, Akinobu Nakamura, Takahisa Handa, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, So Nagai, Hideaki Miyoshi, Tatsuya Atsumi. J Diabetes Investig 2021
3

Continuous glucose monitoring to assess glycemic control in the first 6 weeks after pancreas transplantation.
Vikash Dadlani, Ravinder Jeet Kaur, Mark Stegall, Souzana-Eirini Xyda, Kanchan Kumari, Keisha Bonner, Byron Smith, Prabin Thapa, Patrick G Dean, Yogish C Kudva. Clin Transplant 2019
1

Update on biomarkers of glycemic control.
Maja Krhač, Marijana Vučić Lovrenčić. World J Diabetes 2019
16

The application of simple metrics in the assessment of glycaemic variability.
L Monnier, C Colette, D R Owens. Diabetes Metab 2018
34

Glycemic variability: adverse clinical outcomes and how to improve it?
Zheng Zhou, Bao Sun, Shiqiong Huang, Chunsheng Zhu, Meng Bian. Cardiovasc Diabetol 2020
8

Validation of Time in Range as an Outcome Measure for Diabetes Clinical Trials.
Roy W Beck, Richard M Bergenstal, Tonya D Riddlesworth, Craig Kollman, Zhaomian Li, Adam S Brown, Kelly L Close. Diabetes Care 2019
170


[Impact of physical activity on glycemic variability in people with diabetes mellitus type 2].
A von Oetinger G, L M Trujillo G, N Soto I. Rehabilitacion (Madr) 2021
0

GLU: a software package for analysing continuously measured glucose levels in epidemiology.
Louise A C Millard, Nashita Patel, Kate Tilling, Melanie Lewcock, Peter A Flach, Debbie A Lawlor. Int J Epidemiol 2020
0

A Review of Continuous Glucose Monitoring-Based Composite Metrics for Glycemic Control.
Michelle Nguyen, Julia Han, Elias K Spanakis, Boris P Kovatchev, David C Klonoff. Diabetes Technol Ther 2020
6


Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes.
Guillermo E Umpierrez, Boris P Kovatchev. Am J Med Sci 2018
23

New Paradigm of Personalized Glycemic Control Using Glucose Temporal Density Histograms.
Uriel Trahtemberg, Tova Hallas, Yehonatan Segman, Ella Sheiman, Michal Shasha, Kobi Nissim, Yosef Joseph Segman. J Diabetes Sci Technol 2019
0

Glycemic deviation index: a novel method of integrating glycemic numerical value and variability.
Yizhou Zou, Wanli Wang, Dongmei Zheng, Xu Hou. BMC Endocr Disord 2021
0

Glycemic variability and cardiovascular disease in patients with type 2 diabetes.
Marcela Martinez, Jimena Santamarina, Adrian Pavesi, Carla Musso, Guillermo E Umpierrez. BMJ Open Diabetes Res Care 2021
0

The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study.
Takahisa Handa, Akinobu Nakamura, Aika Miya, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, So Nagai, Narihito Yoshioka, Hideaki Miyoshi, Tatsuya Atsumi. Diabetol Metab Syndr 2021
0



One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology.
Marc D Breton, Boris P Kovatchev. Diabetes Technol Ther 2021
0

Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study.
Thomas Blevins, Wendy Lane, David Rodbard, Dana Sindelar, Ludi Fan, Kelly Ellinor, Liza Ilag, Trang Ly, Jennal Johnson. Diabetes Technol Ther 2021
1

Anticipation of Historical Exercise Patterns by a Novel Artificial Pancreas System Reduces Hypoglycemia During and After Moderate-Intensity Physical Activity in People with Type 1 Diabetes.
Jose Garcia-Tirado, Sue A Brown, Nitchakarn Laichuthai, Patricio Colmegna, Chaitanya L K Koravi, Basak Ozaslan, John P Corbett, Charlotte L Barnett, Michael Pajewski, Mary C Oliveri,[...]. Diabetes Technol Ther 2021
1

Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes.
Ana Colás, Manuel Varela, Milos Mraz, Daniel Novak, David Cuesta-Frau, Luis Vigil, Marek Benes, Terezie Pelikanova, Martin Haluzik, Vaclav Burda,[...]. Diabetes Metab Res Rev 2020
0


Impacts of glycemic variability on the relationship between glucose management indicator from iPro2 and laboratory hemoglobin A1c in adult patients with type 1 diabetes mellitus.
Hongxia Liu, Daizhi Yang, Hongrong Deng, Wen Xu, Jing Lv, Yongwen Zhou, Sihui Luo, Xueying Zheng, Hua Liang, Bin Yao,[...]. Ther Adv Endocrinol Metab 2020
1

Glycemic Variability: Risk Factors, Assessment, and Control.
Boris Kovatchev. J Diabetes Sci Technol 2019
8

Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program.
Thomas Danne, Bertrand Cariou, John B Buse, Satish K Garg, Julio Rosenstock, Phillip Banks, Jake A Kushner, Darren K McGuire, Anne L Peters, Sangeeta Sawhney,[...]. Diabetes Care 2019
29

Standardization process of continuous glucose monitoring: Traceability and performance.
Guido Freckmann, James H Nichols, Rolf Hinzmann, David C Klonoff, Yi Ju, Peter Diem, Konstantinos Makris, Robbert J Slingerland. Clin Chim Acta 2021
1

Estimation of Hemoglobin A1c from Continuous Glucose Monitoring Data in Individuals with Type 1 Diabetes: Is Time In Range All We Need?
Chiara Fabris, Lutz Heinemann, Roy Beck, Claudio Cobelli, Boris Kovatchev. Diabetes Technol Ther 2020
5

Insulin glargine/lixisenatide fixed-ratio combination improves glycaemic variability and control without increasing hypoglycaemia.
Ronnie Aronson, Guillermo Umpierrez, William Stager, Boris Kovatchev. Diabetes Obes Metab 2019
5

Continuous Glucose Monitoring: A Brief Review for Primary Care Practitioners.
Ramzi Ajjan, David Slattery, Eugene Wright. Adv Ther 2019
13

Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.
Rodolfo J Galindo, Roy W Beck, Maria F Scioscia, Guillermo E Umpierrez, Katherine R Tuttle. Endocr Rev 2020
4

Log-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring.
Aika Miya, Akinobu Nakamura, Takahisa Handa, Hiroshi Nomoto, Hiraku Kameda, Kyu Yong Cho, So Nagai, Yoichi M Ito, Hideaki Miyoshi, Tatsuya Atsumi. Sci Rep 2021
0

A View Beyond HbA1c: Role of Continuous Glucose Monitoring.
Haleh Chehregosha, Mohammad E Khamseh, Mojtaba Malek, Farhad Hosseinpanah, Faramarz Ismail-Beigi. Diabetes Ther 2019
28

Choice of Continuous Glucose Monitoring Systems May Affect Metrics: Clinically Relevant Differences in Times in Ranges.
Guido Freckmann, Stefan Pleus, Sebastian Schauer, Manuela Link, Nina Jendrike, Delia Waldenmaier, Cornelia Haug, Andreas Stuhr. Exp Clin Endocrinol Diabetes 2021
1

Yet Another Glucose Variability Index: Time for a Paradigm Change?
Claudio Cobelli, Andrea Facchinetti. Diabetes Technol Ther 2018
6

Low Blood Glucose Index and Hypoglycaemia Risk: Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in Type 2 Diabetes.
Boris Kovatchev, Zhaoling Meng, Anna M G Cali, Riccardo Perfetti, Marc D Breton. Diabetes Ther 2020
0

Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?
Louis Monnier, Anne Wojtusciszyn, Nicolas Molinari, Claude Colette, Eric Renard, David Owens. Diabetes Care 2020
8